Rima Chakrabarti, MD

Rima is co-founder and managing partner of RBL Ventures and is currently acting CEO of RBL Ventures’ first portfolio company, Sentinel BioTherapeutics. Previously, Rima was a Partner at KdT Ventures for 5 years, investing in a portfolio of companies spanning human and climate health. Rima started her career as a neurologist at the University of Pennsylvania and is a physician-scientist trained at the University of Texas Southwestern Medical Center. Her research on lipid metabolism and cholesterol homeostasis under Dr. Helen Hobbs was funded by the Howard Hughes Medical Institute.